Label: REDNESS SOLUTIONS DAILY PROTECTIVE BASE BROAD SPECTRUM SPF 15- titanium dioxide and zinc oxide cream
- NDC Code(s): 49527-019-01, 49527-019-02
- Packager: CLINIQUE LABORATORIES LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated February 25, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredients
- Purpose
- Use
- Warnings
-
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- reapply at least every two hours
- use a water resistant sunscreen if swimming or sweating
-
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeved shirts, pants, hats and sunglasses
- children under 6 months of age: ask a doctor
-
Inactive ingredients
water\aqua\eau,methyl trimethicone,octyldodecyl neopentanoate,c12-15 alkyl benzoate,butylene glycol,tricaprylyl citrate,steareth-2,trioctyldodecyl citrate,glyceryl stearate,peg-100 stearate,barium sulfate,silica,dimethicone,sodium hyaluronate,panthenol,ascophyllum nodosum extract,asparagopsis armata extract,caffeine,lactobacillus ferment,bisabolol,sorbitol,phytosphingosine,caprylyl glycol,polyhydroxystearic acid,aluminum hydroxide,sucrose,cetearyl alcohol,stearic acid,hexylene glycol,xanthan gum,isostearic acid,tocopheryl acetate,magnesium ascorbyl phosphate,disodium edta,phenoxyethanol,iron oxides (ci 77491),iron oxides (ci 77492),iron oxides (ci 77499),chromium hydroxide green (ci 77289) <iln52548>
- Other information
- PRINCIPAL DISPLAY PANEL - 40 ml Bottle Carton
-
INGREDIENTS AND APPEARANCE
REDNESS SOLUTIONS DAILY PROTECTIVE BASE BROAD SPECTRUM SPF 15
titanium dioxide and zinc oxide creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:49527-019 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 65 mg in 1 mL ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 25 mg in 1 mL Inactive Ingredients Ingredient Name Strength ASCOPHYLLUM NODOSUM (UNII: 168S4EO8YJ) POLYHYDROXYSTEARIC ACID (2300 MW) (UNII: YXH47AOU0F) LIMOSILACTOBACILLUS REUTERI (UNII: 9913I24QEE) HYALURONATE SODIUM (UNII: YSE9PPT4TH) SORBITOL (UNII: 506T60A25R) PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q) CAPRYLYL GLYCOL (UNII: 00YIU5438U) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) STEARIC ACID (UNII: 4ELV7Z65AP) HEXYLENE GLYCOL (UNII: KEH0A3F75J) XANTHAN GUM (UNII: TTV12P4NEE) EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM) PHENOXYETHANOL (UNII: HIE492ZZ3T) FERRIC OXIDE RED (UNII: 1K09F3G675) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) CHROMIUM HYDROXIDE GREEN (UNII: RV8FT8XF5R) WATER (UNII: 059QF0KO0R) METHYL TRIMETHICONE (UNII: S73ZQI0GXM) OCTYLDODECYL NEOPENTANOATE (UNII: X8725R883T) ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) TRICAPRYLYL CITRATE (UNII: BXW1GAI4TA) GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) PEG-100 STEARATE (UNII: YD01N1999R) BARIUM SULFATE (UNII: 25BB7EKE2E) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) SUCROSE (UNII: C151H8M554) CAFFEINE (UNII: 3G6A5W338E) DIMETHICONE (UNII: 92RU3N3Y1O) CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S) ISOSTEARIC ACID (UNII: X33R8U0062) LEVOMENOL (UNII: 24WE03BX2T) MAGNESIUM ASCORBYL PHOSPHATE (UNII: 0R822556M5) STEARETH-2 (UNII: V56DFE46J5) TRIOCTYLDODECYL CITRATE (UNII: 35X8CT063R) ASPARAGOPSIS ARMATA (UNII: 2936KN6I1G) ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) LIMOSILACTOBACILLUS FERMENTUM (UNII: 2C1F12C6AP) PANTHENOL (UNII: WV9CM0O67Z) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:49527-019-01 1 in 1 CARTON 12/01/2011 1 40 mL in 1 BOTTLE; Type 0: Not a Combination Product 2 NDC:49527-019-02 15 mL in 1 TUBE; Type 0: Not a Combination Product 12/01/2022 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M020 12/01/2011 Labeler - CLINIQUE LABORATORIES LLC (044475127) Registrant - Estee Lauder Companies Inc. (790802086) Establishment Name Address ID/FEI Business Operations The Estee Lauder Inc 802599436 pack(49527-019) , label(49527-019) , manufacture(49527-019) Establishment Name Address ID/FEI Business Operations NORTHTEC LLC 943871157 pack(49527-019) , label(49527-019)
